It is a multinational study investigating the safety and efficacy of biphasic insulin aspart 30/70 (BIAsp 30) in the routine management of patients with Type 2 diabetes mellitus. Five published ...
A trial conducted in eight countries, including India has shown that using biphasic BIAsp 30 insulin can lead to significant clinical improvements and greater patient satisfaction. A trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback